Global Gastrointestinal OTC Drugs Market Research Report 2017

Publisher Name :
Date: 13-Nov-2017
No. of pages: 114
Inquire Before Buying

In this report, the global Gastrointestinal OTC Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal OTC Drugs in these regions, from 2012 to 2022 (forecast), covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Global Gastrointestinal OTC Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- Bayer

- GlaxoSmithKline

- Johnson & Johnson

- Pfizer

- Perrigo

- Abbott

- C.B. Fleet

- Purdue Pharma

- Teva Pharmaceutical

- Sanofi

- Boehringer Ingelheim

- Xiuzheng Pharmaceutical Group

- China Resources Sanjiu Medical & Pharmaceutical

- Harbin Pharmaceutical Group

- JZJT

- Tongrentang (TRT)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Capsule

- Tablet

- Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Gastrointestinal OTC Drugs Market Research Report 2017

Table of Contents
Global Gastrointestinal OTC Drugs Market Research Report 2017
1 Gastrointestinal OTC Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal OTC Drugs
1.2 Gastrointestinal OTC Drugs Segment by Type (Product Category)
1.2.1 Global Gastrointestinal OTC Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Gastrointestinal OTC Drugs Production Market Share by Type (Product Category) in 2016
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Others
1.3 Global Gastrointestinal OTC Drugs Segment by Application
1.3.1 Gastrointestinal OTC Drugs Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Gastrointestinal OTC Drugs Market by Region (2012-2022)
1.4.1 Global Gastrointestinal OTC Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Gastrointestinal OTC Drugs (2012-2022)
1.5.1 Global Gastrointestinal OTC Drugs Revenue Status and Outlook (2012-2022)
1.5.2 Global Gastrointestinal OTC Drugs Capacity, Production Status and Outlook (2012-2022)
2 Global Gastrointestinal OTC Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal OTC Drugs Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Gastrointestinal OTC Drugs Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Gastrointestinal OTC Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Gastrointestinal OTC Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal OTC Drugs Market Concentration Rate
2.5.2 Gastrointestinal OTC Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Gastrointestinal OTC Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Gastrointestinal OTC Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Gastrointestinal OTC Drugs Production and Market Share by Region (2012-2017)
3.3 Global Gastrointestinal OTC Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Gastrointestinal OTC Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Gastrointestinal OTC Drugs Consumption by Region (2012-2017)
4.2 North America Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2012-2017)
5 Global Gastrointestinal OTC Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Gastrointestinal OTC Drugs Production and Market Share by Type (2012-2017)
5.2 Global Gastrointestinal OTC Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Gastrointestinal OTC Drugs Price by Type (2012-2017)
5.4 Global Gastrointestinal OTC Drugs Production Growth by Type (2012-2017)
6 Global Gastrointestinal OTC Drugs Market Analysis by Application
6.1 Global Gastrointestinal OTC Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Gastrointestinal OTC Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Gastrointestinal OTC Drugs Manufacturers Profiles/Analysis
7.1 Bayer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bayer Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 GlaxoSmithKline
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 GlaxoSmithKline Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Johnson & Johnson
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Pfizer
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Pfizer Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Perrigo
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Perrigo Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Abbott
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Abbott Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 C.B. Fleet
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 C.B. Fleet Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Purdue Pharma
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Purdue Pharma Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Teva Pharmaceutical
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Sanofi
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Sanofi Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Boehringer Ingelheim
7.12 Xiuzheng Pharmaceutical Group
7.13 China Resources Sanjiu Medical & Pharmaceutical
7.14 Harbin Pharmaceutical Group
7.15 JZJT
7.16 Tongrentang (TRT)
8 Gastrointestinal OTC Drugs Manufacturing Cost Analysis
8.1 Gastrointestinal OTC Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gastrointestinal OTC Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Gastrointestinal OTC Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Gastrointestinal OTC Drugs Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Gastrointestinal OTC Drugs Market Forecast (2017-2022)
12.1 Global Gastrointestinal OTC Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Gastrointestinal OTC Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Gastrointestinal OTC Drugs Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Gastrointestinal OTC Drugs Price and Trend Forecast (2017-2022)
12.2 Global Gastrointestinal OTC Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Gastrointestinal OTC Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Gastrointestinal OTC Drugs Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Gastrointestinal OTC Drugs
Figure Global Gastrointestinal OTC Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Gastrointestinal OTC Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Capsule
Table Major Manufacturers of Capsule
Figure Product Picture of Tablet
Table Major Manufacturers of Tablet
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Gastrointestinal OTC Drugs Consumption (K Pcs) by Applications (2012-2022)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share by Applications in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Global Gastrointestinal OTC Drugs Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Gastrointestinal OTC Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Gastrointestinal OTC Drugs Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Gastrointestinal OTC Drugs Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Gastrointestinal OTC Drugs Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Gastrointestinal OTC Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Gastrointestinal OTC Drugs Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Gastrointestinal OTC Drugs Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Gastrointestinal OTC Drugs Major Players Product Production (K Pcs) (2012-2017)
Table Global Gastrointestinal OTC Drugs Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Gastrointestinal OTC Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Gastrointestinal OTC Drugs Production Share by Manufacturers
Figure 2017 Gastrointestinal OTC Drugs Production Share by Manufacturers
Figure Global Gastrointestinal OTC Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Gastrointestinal OTC Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers
Table 2017 Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers
Table Global Market Gastrointestinal OTC Drugs Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Gastrointestinal OTC Drugs Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Gastrointestinal OTC Drugs Product Category
Figure Gastrointestinal OTC Drugs Market Share of Top 3 Manufacturers
Figure Gastrointestinal OTC Drugs Market Share of Top 5 Manufacturers
Table Global Gastrointestinal OTC Drugs Capacity (K Pcs) by Region (2012-2017)
Figure Global Gastrointestinal OTC Drugs Capacity Market Share by Region (2012-2017)
Figure Global Gastrointestinal OTC Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal OTC Drugs Capacity Market Share by Region
Table Global Gastrointestinal OTC Drugs Production by Region (2012-2017)
Figure Global Gastrointestinal OTC Drugs Production (K Pcs) by Region (2012-2017)
Figure Global Gastrointestinal OTC Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal OTC Drugs Production Market Share by Region
Table Global Gastrointestinal OTC Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2012-2017)
Figure Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Gastrointestinal OTC Drugs Revenue Market Share by Region
Figure Global Gastrointestinal OTC Drugs Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Gastrointestinal OTC Drugs Consumption (K Pcs) Market by Region (2012-2017)
Table Global Gastrointestinal OTC Drugs Consumption Market Share by Region (2012-2017)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal OTC Drugs Consumption (K Pcs) Market Share by Region
Table North America Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Gastrointestinal OTC Drugs Production (K Pcs) by Type (2012-2017)
Table Global Gastrointestinal OTC Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Gastrointestinal OTC Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Gastrointestinal OTC Drugs by Type
Table Global Gastrointestinal OTC Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Gastrointestinal OTC Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Gastrointestinal OTC Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Gastrointestinal OTC Drugs by Type
Table Global Gastrointestinal OTC Drugs Price (USD/Pcs) by Type (2012-2017)
Figure Global Gastrointestinal OTC Drugs Production Growth by Type (2012-2017)
Table Global Gastrointestinal OTC Drugs Consumption (K Pcs) by Application (2012-2017)
Table Global Gastrointestinal OTC Drugs Consumption Market Share by Application (2012-2017)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share by Application in 2016
Table Global Gastrointestinal OTC Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Gastrointestinal OTC Drugs Consumption Growth Rate by Application (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure Bayer Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure Bayer Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure Pfizer Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure Pfizer Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table Perrigo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Perrigo Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Perrigo Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure Perrigo Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure Perrigo Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure Abbott Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure Abbott Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table C.B. Fleet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table C.B. Fleet Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure C.B. Fleet Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure C.B. Fleet Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure C.B. Fleet Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table Purdue Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Purdue Pharma Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Purdue Pharma Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure Purdue Pharma Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure Purdue Pharma Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Gastrointestinal OTC Drugs Production Growth Rate (2012-2017)
Figure Sanofi Gastrointestinal OTC Drugs Production Market Share (2012-2017)
Figure Sanofi Gastrointestinal OTC Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal OTC Drugs
Figure Manufacturing Process Analysis of Gastrointestinal OTC Drugs
Figure Gastrointestinal OTC Drugs Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal OTC Drugs Major Manufacturers in 2016
Table Major Buyers of Gastrointestinal OTC Drugs
Table Distributors/Traders List
Figure Global Gastrointestinal OTC Drugs Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal OTC Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Gastrointestinal OTC Drugs Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Gastrointestinal OTC Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Gastrointestinal OTC Drugs Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Gastrointestinal OTC Drugs Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Gastrointestinal OTC Drugs Production (K Pcs) Forecast by Type (2017-2022)
Table Global Gastrointestinal OTC Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Gastrointestinal OTC Drugs Price Forecast by Type (2017-2022)
Table Global Gastrointestinal OTC Drugs Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Gastrointestinal OTC Drugs Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Gastritis - Pipeline Review, H2 2017
    Published: 07-Nov-2017        Price: US 2000 Onwards        Pages: 51
    Gastritis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Pipeline Review, H2 2017, provides an overview of the Gastritis (Gastrointestinal) pipeline landscape. Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gast......
  • Irritable Bowel Syndrome - Pipeline Review, H2 2017
    Published: 07-Nov-2017        Price: US 2000 Onwards        Pages: 154
    Irritable Bowel Syndrome - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2017, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape. Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. Si......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Gastrointestinal Drug Market 2017 Forecast to 2022
    Published: 06-Nov-2017        Price: US 4880 Onwards        Pages: 121
    Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders. Scope of the Report: This report focuses on the Gastrointestinal Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes......
  • Short Bowel Syndrome - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Short Bowel Syndrome - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Short Bowel Syndrome for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Short Bowel Syndrome . It enables understand......
  • Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients af......
  • Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Gastric Ulcers. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Gastric Ulcers which can turn out t......
  • Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 40
    DelveInsight's, Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Helicobacter Pylori Infections. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Hel......
  • Traveler's Diarrhea - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Traveler's Diarrhea - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Traveler's Diarrhea for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Traveler's Diarrhea . It enables understanding......
  • Celiac Disease (CD)-Market Insights, Epidemiology and Market Forecast-2023
    Published: 01-Nov-2017        Price: US 4950 Onwards        Pages: 67
    DelveInsight's "Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023" report provides an overview of the disease and global market size of the Celiac Disease for the 6MM (United States and EU5 countries (France, Germany, Italy, Spain and UK)). It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease from 2013-2023. Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs